Improve signal-to-noise ratio
The high and costly failure rate of clinical trials is due in large part to imprecise endpoint measurements that add noise and impair signal detection.
Our platform combines cohesive, interoperable electronic Clinical Outcomes Assessment (eCOA) software and accurate, expert clinician services to improve the collection, management, and analysis of clinical study data.
This results in a dramatic improvement in clinical assessment accuracy and a smoother, more direct path to market.
Industry-leading scientific measurement and data quality
Smart scientific design: Measurement science and eCOA expertise are applied to the design and configuration of your solution.
Overall improved data quality: Our unique form-builder technology incorporates edit checks and clinical guidance to ensure the data captured in the assessments is accurate. Our remote data capture service for patients and caregivers delivers immediate item-by-item uploads to our database, minimizing risk of data loss.
Built with patients, for patients
Patient Adherence: We create study solutions with a deep understanding of measurement science and functional design to help ensure questionnaires are completed to minimize missing entries. Patients complete questionnaires as required through use of reminders and alerts, while date/time stamping documents protocol adherence.
Patient Engagement: Patients are engaged throughout the study through messaging, availability of additional training, and notifications of study visits and study information. Real-time monitoring of patients is enabled by sites through our eCOA/ePRO platform to view compliance, messages from patients and patient status.
Rapid setup and easy deployment
Quick development times: We leverage our proprietary form-builder technology to enable views of the system as early as the kick-off meetings with sponsors, including completion of the system in only 4-6 weeks—quicker than any other eCOA provider.
Ease of enrollment: Avoid problems associated with manual entry of study/patient numbers into devices through the use of QR code technology.
Our eCOA/ePRO Platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and speeds trials. Such a system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized, accurate studies.
The ultimate beneficiaries of clearer signals and reduced administrative burden are of course CNS patients and their families. Their quality of life depends on medical advances, advances that improvements in the clinical trial process have vast potential to accelerate.
CHART DATA SOURCE: Negash S, et al. Virgil investigative study platform minimizes scoring discrepancies to improve signal detection. Presented at AAIC 2016, Toronto, Canada. F(1,298) = 38.4 p<.0001
To see WCG’s eCOA/ePRO platform in action, schedule a demo and consultation today.
The eCOA/ePRO platform–along with our complete suite of clinical services–make WCG the most proficient and reliable global partner for improved outcome measurement and smarter, faster, and more successful clinical trials.